{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:26:53Z","timestamp":1790767613674,"version":"4.1.0"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Matrouh University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It has been reported that corticosteroid therapy was effective in the management of severe acute respiratory syndrome (SARS) and the Middle East Respiratory Syndrome (MERS), and recently in coronavirus disease 2019 (COVID-19). Corticosteroids are potent anti-inflammatory drugs that mitigate the risk of acute respiratory distress syndrome (ARDS) in COVID-19 and other viral pneumonia, despite a reduction of viral clearance; corticosteroids inhibit the development of cytokine storm and multi-organ damage. The risk\u2013benefit ratio should be assessed for critical COVID-19 patients. In conclusion, corticosteroid therapy is an effective way in the management of COVID-19, it reduces the risk of complications primarily acute lung injury and the development of ARDS. Besides, corticosteroid therapy mainly dexamethasone and methylprednisolone are effective in reducing the severity of COVID-19 and associated comorbidities such as chronic obstructive pulmonary diseases (COPD), rheumatoid arthritis, and inflammatory bowel disease (IBD).<\/jats:p>","DOI":"10.1007\/s10787-022-00987-z","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T19:14:03Z","timestamp":1652469243000},"page":"1189-1205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["COVID-19 and corticosteroids: a narrative review"],"prefix":"10.1007","volume":"30","author":[{"given":"Gaber","family":"El-Saber Batiha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-7300","authenticated-orcid":false,"given":"Hebatallah M.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"issue":"6","key":"987_CR1","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.kint.2020.04.002","volume":"97","author":"F Alberici","year":"2020","unstructured":"Alberici F et al (2020) A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney Int 97(6):1083\u20131088","journal-title":"Kidney Int"},{"issue":"5","key":"987_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/bbrj.bbrj_105_20","volume":"4","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Hussien NR, Al-Naimi MS, Al-Buhadily AK, Al-Gareeb AI, Lungnier C (2020a) Renin-angiotensin system and fibrinolytic pathway in COVID-19: one-way skepticism. Biomed Biotechnol Res J 4(5):33","journal-title":"Biomed Biotechnol Res J"},{"key":"987_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fmed.2021.644295","volume":"8","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Cruz-Martins N, Batiha GE (2021b) COVID-19 and risk of acute ischemic stroke and acute lung injury in patients with type ii diabetes mellitus: the anti-inflammatory role of metformin. Front Med 8:110","journal-title":"Front Med"},{"key":"987_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fcvm.2021.644095","volume":"8","author":"H Al-kuraishy","year":"2021","unstructured":"Al-kuraishy H, Al-Gareeb AI, Guerreiro SG, Cruz-Martins N, Batiha GE (2021c) COVID-19 in relation to hyperglycemia and diabetes mellitus. Front Cardiovasc Med 8:335","journal-title":"Front Cardiovasc Med"},{"key":"987_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.649128","volume":"8","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Faidah H, Al-Maiahy TJ, Cruz-Martins N, Batiha GE (2021d) The looming effects of estrogen in Covid-19: a rocky rollout. Front Nutr 8:649128","journal-title":"Front Nutr"},{"issue":"11","key":"987_CR4","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1007\/s11010-021-04232-z","volume":"476","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Cruz-Martins N, Batiha GE (2021e) The potential role of neopterin in Covid-19: a new perspective. Mol Cell Biochem 476(11):4161\u20134166","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"987_CR5","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1007\/s11033-021-06770-7","volume":"48","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Alexiou A, Batiha GE (2021f) Niclosamide for Covid-19: bridging the gap. Mol Biol Rep 48(12):8195\u20138202","journal-title":"Mol Biol Rep"},{"key":"987_CR67","doi-asserted-by":"publisher","first-page":"108516","DOI":"10.1016\/j.intimp.2021.108516","volume":"6","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NA, Alexiou A, Batiha GE (2022g) Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality. Int Immunopharmacol 6:108516","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"987_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/14787210.2017.1271712","volume":"15","author":"JA Al-Tawfiq","year":"2017","unstructured":"Al-Tawfiq JA, Memish ZA (2017) Update on therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV). Expert Rev Anti Infect Ther 15(3):269\u2013275","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"987_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jinf.2004.09.008","volume":"51","author":"TW Auyeung","year":"2005","unstructured":"Auyeung TW et al (2005) The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study. J Infect 51(2):98\u2013102","journal-title":"J Infect"},{"issue":"10","key":"987_CR10","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1111\/all.14420","volume":"75","author":"S Avdeev","year":"2020","unstructured":"Avdeev S et al (2020) Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19. Allergy 75(10):2703\u20132704","journal-title":"Allergy"},{"issue":"1","key":"987_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/TP.0000000000003502","volume":"105","author":"S Bae","year":"2021","unstructured":"Bae S et al (2021) Early changes in kidney transplant immunosuppression regimens during the COVID-19 pandemic. Transplantation 105(1):170\u2013176","journal-title":"Transplantation"},{"issue":"3","key":"987_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/all.13051","volume":"72","author":"J Banuelos","year":"2017","unstructured":"Banuelos J, Cao Y, Shin SC, Lu NZ (2017) Immunopathology alters Th17 cell glucocorticoid sensitivity. Allergy 72(3):331\u2013341","journal-title":"Allergy"},{"issue":"4","key":"987_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13286","volume":"22","author":"M Bartiromo","year":"2020","unstructured":"Bartiromo M et al (2020) Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19). Transpl Infect Dis 22(4):e13286","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"987_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/10253890500100240","volume":"8","author":"ME Bauer","year":"2005","unstructured":"Bauer ME (2005) Stress, glucocorticoids and ageing of the immune system. Stress 8(1):69\u201383","journal-title":"Stress"},{"issue":"1","key":"987_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/TP.0000000000003480","volume":"105","author":"I Benotmane","year":"2021","unstructured":"Benotmane I et al (2021) Biomarkers of cytokine release syndrome predict disease severity and mortality from COVID-19 in kidney transplant recipients. Transplantation 105(1):158\u2013169","journal-title":"Transplantation"},{"issue":"4","key":"987_CR16","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s40618-020-01325-2","volume":"44","author":"AM Berton","year":"2020","unstructured":"Berton AM, Prencipe N, Giordano R, Ghigo E, Grottoli S (2020) Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view. J Endocrinol Invest 44(4):873\u2013875","journal-title":"J Endocrinol Invest"},{"key":"987_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577167","volume":"340","author":"SC Bondy","year":"2020","unstructured":"Bondy SC (2020) Aspects of the immune system that impact brain function. J Neuroimmunol 340:577167","journal-title":"J Neuroimmunol"},{"issue":"1","key":"987_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4046\/trd.2020.0101","volume":"84","author":"B Bouazza","year":"2021","unstructured":"Bouazza B, Hadj-Said D, Pescatore KA, Chahed R (2021) Are patients with asthma and chronic obstructive pulmonary disease preferred targets of COVID-19? Tuberc Respir Dis 84(1):22","journal-title":"Tuberc Respir Dis"},{"issue":"Sup2","key":"987_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2036.1996.22164025.x","volume":"10","author":"R Brattsand","year":"1996","unstructured":"Brattsand R, Linden M (1996) Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 10(Sup2):81\u201390","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"987_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","volume":"159","author":"EJ Brenner","year":"2020","unstructured":"Brenner EJ et al (2020) Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology 159(2):481\u2013491","journal-title":"Gastroenterology"},{"issue":"9","key":"987_CR21","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1164\/rccm.201101-0135OC","volume":"183","author":"C Brun-Buisson","year":"2011","unstructured":"Brun-Buisson C, Richard JC, Mercat A, Thi\u00e9baut AC, Brochard L (2011) Early corticosteroids in severe influenza A\/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 183(9):1200\u20131206","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"987_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/ibd\/izaa278","volume":"27","author":"KE Burke","year":"2021","unstructured":"Burke KE et al (2021) Immunosuppressive therapy and risk of COVID-19 infection in patients with inflammatory bowel diseases. Inflamm Bowel Dis 27(2):155\u2013161","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"987_CR23","first-page":"S0016","volume":"160","author":"M Cappello","year":"2020","unstructured":"Cappello M, Busacca A, Guida L (2020) The course of Covid 19 in Inflammatory Bowel Disease: protective role of TNF antagonists Response to: corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology 160(5):S0016-5085","journal-title":"Gastroenterology"},{"issue":"1","key":"987_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.21911\/aai.531","volume":"18","author":"E \u00c7elebio\u011flu","year":"2020","unstructured":"\u00c7elebio\u011flu E (2020) Asthma and COVID-19. Asthma Allergy Immunol 18(1):56\u201357","journal-title":"Asthma Allergy Immunol"},{"issue":"3","key":"987_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/00313020600696231","volume":"38","author":"MH Chan","year":"2006","unstructured":"Chan MH et al (2006) Steroid-induced osteonecrosis in severe acute respiratory syndrome: a retrospective analysis of biochemical markers of bone metabolism and corticosteroid therapy. Pathology 38(3):229\u2013235","journal-title":"Pathology"},{"issue":"5","key":"987_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00134-021-06394-2","volume":"47","author":"D Chaudhuri","year":"2021","unstructured":"Chaudhuri D et al (2021) Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. Intensive Care Med 47(5):521\u2013537","journal-title":"Intensive Care Med"},{"issue":"5","key":"987_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13378","volume":"22","author":"TY Chen","year":"2020","unstructured":"Chen TY et al (2020a) COVID-19 pneumonia in kidney transplant recipients: focus on immunosuppression management. Transpl Infect Dis 22(5):e13378","journal-title":"Transpl Infect Dis"},{"issue":"24","key":"987_CR28","doi-asserted-by":"publisher","first-page":"e20481","DOI":"10.1097\/MD.0000000000020481","volume":"99","author":"D Chen","year":"2020","unstructured":"Chen D et al (2020b) Withdrawing mycophenolate mofetil in treating a young kidney transplant recipient with COVID-19: a case report. Medicine 99(24):e20481","journal-title":"Medicine"},{"issue":"5","key":"987_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13329","volume":"22","author":"D Cheng","year":"2020","unstructured":"Cheng D, Wen J, Liu Z, Lv T, Chen JS (2020a) Coronavirus disease 2019 in renal transplant recipients: report of two cases. Transpl Infect Dis 22(5):e13329","journal-title":"Transpl Infect Dis"},{"key":"987_CR30","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3389\/fphar.2020.571156","volume":"11","author":"W Cheng","year":"2020","unstructured":"Cheng W et al (2020b) Efficacy and safety of corticosteroid treatment in patients with COVID-19: a systematic review and meta-analysis. Front Pharmacol 11:1378","journal-title":"Front Pharmacol"},{"issue":"6","key":"987_CR31","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/cid\/ciaa768","volume":"72","author":"T Chroboczek","year":"2021","unstructured":"Chroboczek T et al (2021) Corticosteroids in patients with COVID-19: what about the control group? Clin Infect Dis 72(6):1102\u20131103","journal-title":"Clin Infect Dis"},{"key":"987_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-020-01805-8","author":"L Corral","year":"2020","unstructured":"Corral L et al (2020) GLUCOCOVID: a controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia. MedRxiv. https:\/\/doi.org\/10.1007\/s00508-020-01805-8","journal-title":"MedRxiv"},{"issue":"9","key":"987_CR33","first-page":"1331","volume":"2","author":"J Coyle","year":"2020","unstructured":"Coyle J, Igbinomwanhia E, Sanchez-Nadales A, Danciu S, Chu C, Shah N (2020) A recovered case of COVID-19 myocarditis and ARDS treated with corticosteroids, tocilizumab, and experimental AT-001. Case Rep 2(9):1331\u20131336","journal-title":"Case Rep"},{"issue":"1","key":"987_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5603\/ARM.a2020.0173","volume":"89","author":"K Deokar","year":"2021","unstructured":"Deokar K, Agarwal M, Dutt N, Chauhan N, Niwas R, Shadrach BJ, Chawla G (2021) A review of Ciclesonide in COVID-19. Still a long way to go. Adv Respir Med 89(1):79\u201381","journal-title":"Adv Respir Med"},{"issue":"4","key":"987_CR35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10787-020-00701-x","volume":"28","author":"F Djaballah-Ider","year":"2020","unstructured":"Djaballah-Ider F, Touil-Boukoffa C (2020) Effect of combined colchicine-corticosteroid treatment on neutrophil\/lymphocyte ratio: a predictive marker in Beh\u00e7et disease activity. Inflammopharmacology 28(4):819\u2013829","journal-title":"Inflammopharmacology"},{"issue":"1","key":"987_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/TP.0000000000003528","volume":"105","author":"B Dom\u00ednguez-Gil","year":"2021","unstructured":"Dom\u00ednguez-Gil B et al (2021) Organ donation and transplantation during the COVID-19 pandemic: a summary of the Spanish experience. Transplantation 105(1):29\u201336","journal-title":"Transplantation"},{"issue":"2","key":"987_CR37","doi-asserted-by":"publisher","first-page":"2000172","DOI":"10.1002\/adtp.202000172","volume":"4","author":"T Dube","year":"2020","unstructured":"Dube T, Ghosh A, Mishra J, Kompella UB, Panda JJ (2020) Repurposed drugs, molecular vaccines, immune-modulators, and nanotherapeutics to treat and prevent COVID-19 associated with SARS-CoV-2, a deadly nanovector. Adv Ther 4(2):2000172","journal-title":"Adv Ther"},{"issue":"6","key":"987_CR38","doi-asserted-by":"publisher","first-page":"2002808","DOI":"10.1183\/13993003.02808-2020","volume":"56","author":"M Edalatifard","year":"2020","unstructured":"Edalatifard M et al (2020) Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J 56(6):2002808","journal-title":"Eur Respir J"},{"issue":"5","key":"987_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5152\/TurkThoracJ.2020.20091","volume":"21","author":"E\u00c7 Edis","year":"2020","unstructured":"Edis E\u00c7 (2020) Chronic pulmonary diseases and COVID-19. Turk Thorac J 21(5):345","journal-title":"Turk Thorac J"},{"key":"987_CR40","doi-asserted-by":"publisher","first-page":"hcaa039-060","DOI":"10.1093\/qjmed\/hcaa039.060","volume":"113","author":"SA Elbrassi","year":"2020","unstructured":"Elbrassi SA, Maghawry KM, Ali RM, Abdelhafiez RH (2020) Effectiveness and outcome of methylprednisolone versus hydrocortisone in treatment of acute respiratory distress syndrome (ARDS). QJM Int J Med 113:hcaa039-060","journal-title":"QJM Int J Med"},{"issue":"16","key":"987_CR41","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/cid\/ciaa601","volume":"71","author":"R Fadel","year":"2020","unstructured":"Fadel R et al (2020) Early short-course corticosteroids in hospitalized patients with COVID-19. Clin Infect Dis 71(16):2114\u20132120","journal-title":"Clin Infect Dis"},{"issue":"1","key":"987_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1163\/156856005774423746","volume":"13","author":"LP Filaretova","year":"2005","unstructured":"Filaretova LP, Podvigina TT, Bagaeva TR, Tanaka A, Takeuchi K (2005) Gastroprotective action of glucocorticoid hormones during NSAID treatment. Inflammopharmacology 13(1):27\u201343","journal-title":"Inflammopharmacology"},{"issue":"5","key":"987_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10787-006-1544-2","volume":"14","author":"LP Filaretova","year":"2006","unstructured":"Filaretova LP, Podvigina TT, Bobryshev PY, Bagaeva TR, Tanaka A, Takeuchi K (2006) Hypothalamic-pituitary-adrenocortical axis: the hidden gold in gastric mucosal homeostasis. Inflammopharmacology 14(5):207\u2013213","journal-title":"Inflammopharmacology"},{"issue":"4","key":"987_CR44","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10787-021-00825-8","volume":"29","author":"MA Fokam Tagne","year":"2021","unstructured":"Fokam Tagne MA, Tchoffo A, Noubissi PA, Mazo AG, Kom B, Ngakou Mukam J, Sokeng Dongmo S, Kamgang R (2021) Effects of hydro-ethanolic extract of leaves of Maesa lanceolata (Mursinaceae) on acetic acid-induced ulcerative colitis in rats. Inflammopharmacology 29(4):1211\u20131223","journal-title":"Inflammopharmacology"},{"issue":"4","key":"987_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/apt.15335","volume":"50","author":"EH Forrest","year":"2019","unstructured":"Forrest EH et al (2019) Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis. Aliment Pharmacol Ther 50(4):442\u2013453","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"987_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbi.2009.07.008","volume":"24","author":"MG Frank","year":"2010","unstructured":"Frank MG, Miguel ZD, Watkins LR, Maier SF (2010) Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav Immunity 24(1):19\u201330","journal-title":"Brain Behav Immunity"},{"issue":"2","key":"987_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2302\/kjm.2020-0007-LE","volume":"69","author":"S Fujishima","year":"2020","unstructured":"Fujishima S (2020) COVID-19: stay cool toward corticosteroids. Keio J Med 69(2):27\u201329","journal-title":"Keio J Med"},{"issue":"7","key":"987_CR48","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1111\/ajt.15891","volume":"20","author":"I Gandolfini","year":"2020","unstructured":"Gandolfini I et al (2020) COVID-19 in kidney transplant recipients. Am J Transplant 20(7):1941\u20131943","journal-title":"Am J Transplant"},{"key":"987_CR49","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.17.20069773","author":"KK Gangopadhyay","year":"2020","unstructured":"Gangopadhyay KK, Mukherjee JJ, Sinha B, Ghosal S (2020) The role of corticosteroids in the management of critically ill patients with coronavirus disease 2019 (COVID-19): a meta-analysis. medRxiv. https:\/\/doi.org\/10.1101\/2020.04.17.20069773","journal-title":"medRxiv"},{"issue":"8","key":"987_CR50","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s10067-020-05239-5","volume":"39","author":"C Gazzaruso","year":"2020","unstructured":"Gazzaruso C et al (2020) Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19. Clin Rheumatol 39(8):2475\u20132477","journal-title":"Clin Rheumatol"},{"issue":"2","key":"987_CR51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ciresp.2020.04.030","volume":"99","author":"PG Guardiola","year":"2020","unstructured":"Guardiola PG, Ares J\u00c1, Tom\u00e1s NP, Tom\u00e1s JC, Mart\u00ednez SN (2020) Intestinal perforation in patient with COVID-19 infection treated with tocilizumab and corticosteroids. Report of a clinical case. Cirugia Espan~ola 99(2):156\u2013157","journal-title":"Cirugia Espan~ola"},{"issue":"1","key":"987_CR52","first-page":"57","volume":"22","author":"MM Gurganus","year":"2019","unstructured":"Gurganus MM, Marik PE, Varon J (2019) The successful treatment of severe aspiration pneumonitis with the combination of hydrocortisone, ascorbic acid, and thiamine. Crit Care Shock 22(1):57\u201361","journal-title":"Crit Care Shock"},{"issue":"1","key":"987_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202009-3533SO","volume":"203","author":"DM Halpin","year":"2021","unstructured":"Halpin DM et al (2021) Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 203(1):24-36","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"987_CR54","doi-asserted-by":"publisher","first-page":"2001009","DOI":"10.1183\/13993003.01009-2020","volume":"55","author":"DM Halpin","year":"2020","unstructured":"Halpin DM, Singh D, Hadfield RM (2020) Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J 55(5):2001009. https:\/\/doi.org\/10.1183\/13993003.01009-2020","journal-title":"Eur Respir J"},{"key":"987_CR55","doi-asserted-by":"publisher","DOI":"10.1159\/isbn.978-1-912776-65-8","volume-title":"Fast facts: Asthma for patients and their supporters: information+ taking control= best outcome","author":"J Harrington","year":"2020","unstructured":"Harrington J (2020) Fast facts: Asthma for patients and their supporters: information+ taking control= best outcome. Karger Medical and Scientific Publishers, Basel"},{"issue":"1","key":"987_CR56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1203\/PDR.0b013e31821b502b","volume":"70","author":"KA Hart","year":"2011","unstructured":"Hart KA, Barton MH, Vandenplas ML, Hurley DJ (2011) Effects of low-dose hydrocortisone therapy on immune function in neonatal horses. Pediatr Res 70(1):72\u201377","journal-title":"Pediatr Res"},{"issue":"1","key":"987_CR57","first-page":"10","volume":"59","author":"I Hasan","year":"2020","unstructured":"Hasan I et al (2020a) Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample. Rom J Intern Med 59(1):10\u201342","journal-title":"Rom J Intern Med"},{"issue":"11","key":"987_CR58","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1080\/17476348.2020.1804365","volume":"14","author":"SS Hasan","year":"2020","unstructured":"Hasan SS, Capstick T, Ahmed R, Kow CS, Mazhar F, Merchant HA, Zaidi ST (2020b) Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med 14(11):1149\u20131163","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"987_CR59","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00018-005-5390-y","volume":"63","author":"MJ Herold","year":"2006","unstructured":"Herold MJ, McPherson KG, Reichardt HM (2006) Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 63(1):60\u201372","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"987_CR60","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1002\/art.22204","volume":"54","author":"RK Hoyles","year":"2006","unstructured":"Hoyles RK et al (2006) A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 54(12):3962\u20133970","journal-title":"Arthritis Rheum"},{"key":"987_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110529","volume":"130","author":"Y Hu","year":"2020","unstructured":"Hu Y, Wang T, Hu Z, Wang X, Zhang Z, Li L, Peng P (2020a) Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: a single-center experience. Biomed Pharmacother 130:110529","journal-title":"Biomed Pharmacother"},{"key":"987_CR62","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fpubh.2020.00355","volume":"8","author":"Z Hu","year":"2020","unstructured":"Hu Z et al (2020b) Clinical use of short-course and low-dose corticosteroids in patients with non-severe COVID-19 during pneumonia progression. Front Public Health 8:355","journal-title":"Front Public Health"},{"key":"987_CR63","first-page":"1","volume":"4","author":"Z Hu","year":"2020","unstructured":"Hu Z, Chen W, Liang W, Xu C, Sun W, Yi Y (2020c) Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy\u2014a case report. Ann Hematol 4:1\u20133","journal-title":"Ann Hematol"},{"issue":"7","key":"987_CR64","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1111\/ajt.15896","volume":"20","author":"J Huang","year":"2020","unstructured":"Huang J, Lin H, Wu Y, Fang Y, Kumar R, Chen G, Lin S (2020) COVID-19 in posttransplant patients\u2014report of 2 cases. Am J Transplant 20(7):1879\u20131881","journal-title":"Am J Transplant"},{"issue":"1","key":"987_CR65","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11060-019-03146-7","volume":"143","author":"CY Hui","year":"2019","unstructured":"Hui CY, Rudra S, Ma S, Campian JL, Huang J (2019) Impact of overall corticosteroid exposure during chemoradiotherapy on lymphopenia and survival of glioblastoma patients. J Neuro-Oncol 143(1):129\u2013136","journal-title":"J Neuro-Oncol"},{"issue":"6","key":"987_CR66","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S2468-1253(20)30119-9","volume":"5","author":"M Iacucci","year":"2020","unstructured":"Iacucci M et al (2020) Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period. Lancet Gastroenterol Hepatol 5(6):598\u2013606","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"987_CR68","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jiac.2020.04.007","volume":"26","author":"K Iwabuchi","year":"2020","unstructured":"Iwabuchi K, Yoshie K, Kurakami Y, Takahashi K, Kato Y, Morishima T (2020) Therapeutic potential of ciclesonide inhalation for COVID-19 pneumonia: report of three cases. J Infect Chemother 26(6):625\u2013632","journal-title":"J Infect Chemother"},{"issue":"9","key":"987_CR69","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1093\/cid\/ciaa1177","volume":"72","author":"CM Jeronimo","year":"2021","unstructured":"Jeronimo CM et al (2021) Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): a randomized, double-blind, phase IIb, placebo-controlled trial. Clin Infect Dis 72(9):e373\u2013e381","journal-title":"Clin Infect Dis"},{"issue":"6","key":"987_CR70","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/phar.2410","volume":"40","author":"KM Johnson","year":"2020","unstructured":"Johnson KM, Belfer JJ, Peterson GR, Boelkins MR, Dumkow LE (2020) Managing COVID-19 in renal transplant recipients: a review of recent literature and case supporting corticosteroid-sparing immunosuppression. Pharmacotherapy 40(6):517\u2013524","journal-title":"Pharmacotherapy"},{"issue":"5","key":"987_CR71","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/jcpt.13199","volume":"45","author":"JE Kang","year":"2020","unstructured":"Kang JE, Rhie SJ (2020) Practice considerations on the use of investigational anti-COVID-19 medications: dosage, administration and monitoring. J Clin Pharm Ther 45(5):1199\u20131205","journal-title":"J Clin Pharm Ther"},{"key":"987_CR72","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1111\/liv.14486","volume":"40","author":"H Karimi-Sari","year":"2020","unstructured":"Karimi-Sari H, Rezaee-Zavareh MS (2020) COVID-19 and viral hepatitis elimination programs: are we stepping backward? Liver Int 40:2042\u20132042. https:\/\/doi.org\/10.1111\/liv.14486","journal-title":"Liver Int"},{"key":"987_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.607217","author":"R K\u00f6nig","year":"2021","unstructured":"K\u00f6nig R et al (2021) Use of IFN\u03b3\/IL10 ratio for stratification of hydrocortisone therapy in patients with septic shock. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.607217","journal-title":"Front Immunol"},{"key":"987_CR74","doi-asserted-by":"publisher","first-page":"105168","DOI":"10.1016\/j.psyneuen.2021.105168","volume":"126","author":"OD Kothgassner","year":"2021","unstructured":"Kothgassner OD et al (2021) Hydrocortisone administration for reducing post-traumatic stress symptoms: a systematic review and meta-analysis. Psychoneuroendocrinology 126:105168","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"987_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032280","volume":"7","author":"K Kudo","year":"2012","unstructured":"Kudo K et al (2012) Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A (H1N1) pdm09 in Japan. PLoS ONE 7(2):e32280","journal-title":"PLoS ONE"},{"issue":"6","key":"987_CR76","doi-asserted-by":"publisher","first-page":"L1244","DOI":"10.1152\/ajplung.00144.2020","volume":"318","author":"K Kumar","year":"2020","unstructured":"Kumar K, Hinks TS, Singanayagam A (2020) Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used? Am J Physiol Lung Cell Mol Physiol 318(6):L1244\u2013L1247","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"8","key":"987_CR77","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41565-020-0752-z","volume":"15","author":"T Lammers","year":"2020","unstructured":"Lammers T et al (2020) Dexamethasone nanomedicines for COVID-19. Nat Nanotechnol 15(8):622\u2013624","journal-title":"Nat Nanotechnol"},{"issue":"5","key":"987_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13334","volume":"22","author":"A Lauterio","year":"2020","unstructured":"Lauterio A et al (2020) Successful recovery from severe COVID-19 pneumonia after kidney transplantation: the interplay between immunosuppression and novel therapy including tocilizumab. Transpl Infect Dis 22(5):e13334","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"987_CR79","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/jmv.25952","volume":"92","author":"N Li","year":"2020","unstructured":"Li N, Wang X, Lv T (2020) Prolonged SARS-CoV-2 RNA shedding: not a rare phenomenon. J Med Virol 92(11):2286\u20132287","journal-title":"J Med Virol"},{"issue":"7","key":"987_CR80","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/cid\/ciaa829","volume":"72","author":"S Li","year":"2021","unstructured":"Li S, Hu Z, Song X (2021) High-dose but not low-dose corticosteroids potentially delay viral shedding of patients with COVID-19. Clin Infect Dis 72(7):1297\u20131298","journal-title":"Clin Infect Dis"},{"key":"987_CR81","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3389\/fimmu.2020.01022","volume":"11","author":"Y Liang","year":"2020","unstructured":"Liang Y et al (2020) Highlight of immune pathogenic response and hematopathologic effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 infection. Front Immunol 11:1022","journal-title":"Front Immunol"},{"issue":"1","key":"987_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"TL Liao","year":"2016","unstructured":"Liao TL, Lin CF, Chen YM, Liu HJ, Chen DY (2016) Risk factors and outcomes of nontuberculous mycobacterial disease among rheumatoid arthritis patients: a case-control study in a TB endemic area. Sci Rep 6(1):1\u20131","journal-title":"Sci Rep"},{"key":"987_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106275","volume":"176","author":"SY Liao","year":"2021","unstructured":"Liao SY, Petrache I, Fingerlin TE, Maier LA (2021) Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases. Respir Med 176:106275","journal-title":"Respir Med"},{"issue":"2","key":"987_CR84","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jaci.2020.05.021","volume":"146","author":"J Liu","year":"2020","unstructured":"Liu J, Zheng X, Huang Y, Shan H, Huang J (2020) Successful use of methylprednisolone for treating severe COVID-19. J Allergy Clin Immunol 146(2):325\u2013327","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"987_CR85","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1053\/j.gastro.2020.05.066","volume":"159","author":"DJ Lukin","year":"2020","unstructured":"Lukin DJ et al (2020) Baseline disease activity and steroid therapy stratify risk of COVID-19 in patients with inflammatory bowel disease. Gastroenterology 159(4):1541\u20131544","journal-title":"Gastroenterology"},{"key":"987_CR86","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3389\/fphar.2020.01198","volume":"11","author":"Y Ma","year":"2020","unstructured":"Ma Y et al (2020) Corticosteroid use in the treatment of COVID-19: a multicenter retrospective study in Hunan, China. Front Pharmacol 11:1198","journal-title":"Front Pharmacol"},{"issue":"9","key":"987_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238827","volume":"15","author":"M Majmundar","year":"2020","unstructured":"Majmundar M et al (2020) Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region. PLoS ONE 15(9):e0238827","journal-title":"PLoS ONE"},{"issue":"1","key":"987_CR88","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/jgh.15164","volume":"36","author":"JW Mak","year":"2020","unstructured":"Mak JW, Weng MT, Wei SC, Ng SC (2020) Zero COVID-19 infection in inflammatory bowel disease patients: findings from population-based inflammatory bowel disease registries in Hong Kong and Taiwan. J Gastroenterol Hepatol 36(1):171\u2013173","journal-title":"J Gastroenterol Hepatol"},{"key":"987_CR89","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/hematology.2020000116","volume":"1","author":"L Malpica","year":"2020","unstructured":"Malpica L (2020) Moll S (2020) Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases. Hematology 1:319\u2013327 (2014, the American Society of Hematology Education Program Book)","journal-title":"Hematology"},{"issue":"7","key":"987_CR90","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.rmed.2009.01.003","volume":"103","author":"SC Manson","year":"2009","unstructured":"Manson SC, Brown RE, Cerulli A, Vidaurre CF (2009) The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir Med 103(7):975\u2013994","journal-title":"Respir Med"},{"issue":"3","key":"987_CR91","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccc.2011.05.007","volume":"27","author":"PE Marik","year":"2011","unstructured":"Marik PE, Meduri GU, Rocco PR, Annane D (2011) Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome. Crit Care Clin 27(3):589\u2013607","journal-title":"Crit Care Clin"},{"key":"987_CR92","first-page":"333","volume-title":"Seminars in radiation oncology","author":"LB Marks","year":"2003","unstructured":"Marks LB, Yu X, Vujaskovic Z, Small W Jr, Folz R, Anscher MS (2003) Radiation-induced lung injury. Seminars in radiation oncology. WB Saunders, Philadelphia, pp 333\u2013345"},{"key":"987_CR93","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.11.987016","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama S et al (2020) The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15. BioRxiv. https:\/\/doi.org\/10.1101\/2020.03.11.987016","journal-title":"BioRxiv"},{"key":"987_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2020.103492","volume":"280","author":"P Mattos-Silva","year":"2020","unstructured":"Mattos-Silva P et al (2020) Pros and cons of corticosteroid therapy for COVID-19 patients. Respir Physiol Neurobiol 280:103492","journal-title":"Respir Physiol Neurobiol"},{"issue":"6","key":"987_CR95","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1136\/gutjnl-2020-321183","volume":"69","author":"S Mazza","year":"2020","unstructured":"Mazza S, Sorce A, Peyvandi F, Vecchi M, Caprioli F (2020) A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis. Gut 69(6):1148\u20131149","journal-title":"Gut"},{"issue":"7","key":"987_CR96","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1164\/ajrccm.165.7.2106014","volume":"165","author":"GU Meduri","year":"2002","unstructured":"Meduri GU, Tolley EA, Chrousos GP, Stentz F (2002) Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med AM J 165(7):983\u2013991","journal-title":"Am J Respir Crit Care Med AM J"},{"issue":"6","key":"987_CR97","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1378\/chest.08-2408","volume":"136","author":"GU Meduri","year":"2009","unstructured":"Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE (2009) Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 136(6):1631\u20131643","journal-title":"Chest"},{"issue":"5","key":"987_CR98","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00134-015-4095-4","volume":"42","author":"GU Meduri","year":"2016","unstructured":"Meduri GU, Bridges L, Shih MC, Marik PE, Siemieniuk RA, Kocak M (2016) Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients\u2019 data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med 42(5):829\u2013840","journal-title":"Intensive Care Med"},{"issue":"6","key":"987_CR99","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/CCM.0000000000003021","volume":"46","author":"GU Meduri","year":"2018","unstructured":"Meduri GU, Bridges L, Siemieniuk RA, Kocak M (2018) An exploratory reanalysis of the randomized trial on efficacy of corticosteroids as rescue therapy for the late phase of acute respiratory distress syndrome. Crit Care Med 46(6):884\u2013891","journal-title":"Crit Care Med"},{"issue":"4","key":"987_CR100","first-page":"233","volume":"37","author":"QH Meng","year":"2003","unstructured":"Meng QH, Dong PL, Guo YB, Zhang K, Liang LC, Hou W, Dong JL (2003) Use of glucocorticoid in treatment of severe acute respiratory syndrome cases. Zhonghua Yu Fang Yi Xue Za Zhi [chinese J Prev Med] 37(4):233\u2013235","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi [chinese J Prev Med]"},{"issue":"7","key":"987_CR101","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1111\/ajt.15943","volume":"20","author":"S Meziyerh","year":"2020","unstructured":"Meziyerh S et al (2020) Severe COVID-19 in a renal transplant recipient: a focus on pharmacokinetics. Am J Transplant 20(7):1896\u20131901","journal-title":"Am J Transplant"},{"issue":"19","key":"987_CR102","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.3390\/ijms20194765","volume":"20","author":"D Mokra","year":"2019","unstructured":"Mokra D, Mikolka P, Kosutova P, Mokry J (2019) Corticosteroids in acute lung injury: the dilemma continues. Int J Mol Sci 20(19):4765","journal-title":"Int J Mol Sci"},{"issue":"1","key":"987_CR103","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s00134-020-06311-z","volume":"47","author":"N Mongardon","year":"2021","unstructured":"Mongardon N, Piagnerelli M, Grimaldi D, Perrot B, Lascarrou JB (2021) Impact of late administration of corticosteroids in COVID-19 ARDS. Intensive Care Med 47(1):110\u2013112","journal-title":"Intensive Care Med"},{"issue":"4","key":"987_CR104","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10096-020-04078-1","volume":"40","author":"E Monreal","year":"2021","unstructured":"Monreal E et al (2021) High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study. Eur J Clin Microbiol Infect Dis 40(4):761\u2013769","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"987_CR105","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jmii.2020.09.003","volume":"54","author":"N Mori","year":"2021","unstructured":"Mori N, Katayama M, Nukaga S (2021) Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia. J Microbiol Immunol Infect 54(1):109\u2013112","journal-title":"J Microbiol Immunol Infect"},{"key":"987_CR106","volume-title":"Mayo clinic proceedings","author":"K Nakajima","year":"2020","unstructured":"Nakajima K, Ogawa F, Sakai K, Uchiyama M, Oyama Y, Kato H, Takeuchi I (2020) A case of coronavirus disease 2019 treated with ciclesonide. In: Sps S (ed) Mayo clinic proceedings. Elsevier, Amsterdam"},{"key":"987_CR107","doi-asserted-by":"crossref","unstructured":"Narain S et al (2020) Comparative survival analysis of immunomodulatory therapy for COVID-19'cytokine storm': A retrospective observational cohort study. Northwell COVID-19 Research Consortium, Comparative Survival Analysis of Immunomodulatory Therapy for COVID-19'Cytokine Storm': a retrospective observational cohort study (6\/9\/2020).","DOI":"10.1101\/2020.06.16.20126714"},{"issue":"9","key":"987_CR108","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S2213-2600(20)30314-3","volume":"8","author":"DV Nicolau","year":"2020","unstructured":"Nicolau DV, Bafadhel M (2020) Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med 8(9):846\u2013847","journal-title":"Lancet Respir Med"},{"issue":"5","key":"987_CR109","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1172\/JCI137647","volume":"130","author":"SF Pedersen","year":"2020","unstructured":"Pedersen SF, Ho YC (2020) SARS-CoV-2: a storm is raging. J Clin Investig 130(5):2202\u20132205","journal-title":"J Clin Investig"},{"issue":"11","key":"987_CR110","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1111\/ajt.16314","volume":"20","author":"MR Pereira","year":"2020","unstructured":"Pereira MR et al (2020) Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study. Am J Transplant 20(11):3198\u20133205","journal-title":"Am J Transplant"},{"issue":"01","key":"987_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21477\/ijapsr.6.1.1","volume":"6","author":"Q Pirzada","year":"2021","unstructured":"Pirzada Q, Gul S, Baig F (2021) Treatment with corticosteroids may link to higher risk of COVID-19 disease? Int J Appl Pharm Sci Res 6(01):1\u20137","journal-title":"Int J Appl Pharm Sci Res"},{"issue":"1","key":"987_CR112","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5152\/eurasianjmed.2017.17062","volume":"49","author":"G Polat","year":"2017","unstructured":"Polat G, Ugan RA, Cadirci E, Halici Z (2017) Sepsis and septic shock: current treatment strategies and new approaches. Eurasian J Emerg Med 49(1):53","journal-title":"Eurasian J Emerg Med"},{"issue":"13","key":"987_CR113","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1001\/jama.2020.16747","volume":"324","author":"HC Prescott","year":"2020","unstructured":"Prescott HC, Rice TW (2020) Corticosteroids in COVID-19 ARDS: evidence and hope during the pandemic. JAMA 324(13):1292\u20131295","journal-title":"JAMA"},{"issue":"1","key":"987_CR114","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00134-009-1727-6","volume":"36","author":"AM Quispe-Laime","year":"2010","unstructured":"Quispe-Laime AM, Bracco JD, Barberio PA, Campagne CG, Rolfo VE, Umberger R, Meduri GU (2010) H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med 36(1):33\u201341","journal-title":"Intensive Care Med"},{"issue":"1","key":"987_CR115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-05706-z","volume":"21","author":"K Ranjbar","year":"2021","unstructured":"Ranjbar K et al (2021) Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infect Dis 21(1):1\u20138","journal-title":"BMC Infect Dis"},{"key":"987_CR116","first-page":"211","volume":"3","author":"L Richeldi","year":"2003","unstructured":"Richeldi L, Davies HR, Spagnolo P, Luppi F (2003) Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Datab Syst Rev 3:211\u201319","journal-title":"Cochrane Datab Syst Rev"},{"issue":"3","key":"987_CR117","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1016\/S2665-9913(21)00005-9","volume":"3","author":"PC Robinson","year":"2021","unstructured":"Robinson PC, Morand E (2021) Divergent effects of acute versus chronic glucocorticoids in COVID-19. Lancet Rheumatol 3(3):e168\u2013e170","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"987_CR118","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.cmi.2020.08.010","volume":"27","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2021","unstructured":"Rodr\u00edguez-Ba\u00f1o J et al (2021) Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19). Clin Microbiol Infect 27(2):244\u2013252","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"987_CR119","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/17476348.2021.1850275","volume":"15","author":"P Rogliani","year":"2020","unstructured":"Rogliani P, Lauro D, Di Daniele N, Chetta A, Calzetta L (2020) Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids? Expert Rev Respir Med 15(4):561\u2013568","journal-title":"Expert Rev Respir Med"},{"issue":"11","key":"987_CR120","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1007\/s10067-020-05358-z","volume":"39","author":"R Roongta","year":"2020","unstructured":"Roongta R, Ghosh A (2020) Managing rheumatoid arthritis during COVID-19. Clin Rheumatol 39(11):3237\u20133244","journal-title":"Clin Rheumatol"},{"key":"987_CR121","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijid.2020.09.1486","volume":"101","author":"M Rubio-Rivas","year":"2020","unstructured":"Rubio-Rivas M et al (2020) Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness. Int J Infect Dis 101:290\u2013297","journal-title":"Int J Infect Dis"},{"key":"987_CR122","doi-asserted-by":"publisher","first-page":"106560106560","DOI":"10.1016\/j.intimp.2020.106560","volume":"84","author":"A Saghazadeh","year":"2020","unstructured":"Saghazadeh A, Rezaei N (2020) Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol 84:106560","journal-title":"Int Immunopharmacol"},{"key":"987_CR123","volume-title":"Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia. Open forum infectious diseases US","author":"F Salton","year":"2020","unstructured":"Salton F et al (2020) Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia. Open forum infectious diseases US. Oxford University Press, Oxford"},{"issue":"1","key":"987_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/lungindia.lungindia_473_20","volume":"38","author":"SS Salvi","year":"2021","unstructured":"Salvi SS (2021) Is there a role for inhaled ciclesonide in the treatment of COVID-19? Lung India 38(1):1","journal-title":"Lung India"},{"issue":"4","key":"987_CR125","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10787-014-0205-0","volume":"22","author":"J Scherer","year":"2014","unstructured":"Scherer J, Rainsford KD, Kean CA, Kean WF (2014) Pharmacology of intra-articular triamcinolone. Inflammopharmacology 22(4):201\u2013217","journal-title":"Inflammopharmacology"},{"issue":"11","key":"987_CR126","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S2213-2600(20)30415-X","volume":"8","author":"A Schultze","year":"2020","unstructured":"Schultze A et al (2020) Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med 8(11):1106\u20131120","journal-title":"Lancet Respir Med"},{"issue":"3","key":"987_CR127","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/0970-9290.57361","volume":"20","author":"B Shah","year":"2009","unstructured":"Shah B, Ashok L, Sujatha GP (2009) Evaluation of salivary cortisol and psychological factors in patients with oral lichen planus. Indian J Dent Res 20(3):288","journal-title":"Indian J Dent Res"},{"issue":"10225","key":"987_CR128","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(20)30361-5","volume":"395","author":"L Shang","year":"2020","unstructured":"Shang L, Zhao J, Hu Y, Du R, Cao B (2020) On the use of corticosteroids for 2019-nCoV pneumonia. Lancet (lond, Engl) 395(10225):683","journal-title":"Lancet (lond, Engl)"},{"issue":"7","key":"987_CR129","first-page":"e9038","volume":"12","author":"MV Sheianov","year":"2020","unstructured":"Sheianov MV, Udalov YD, Ochkin SS, Bashkov AN, Samoilov AS (2020) Pulse therapy with corticosteroids and intravenous immunoglobulin in the management of severe tocilizumab-resistant COVID-19: a report of three clinical cases. Cureus 12(7):e9038","journal-title":"Cureus"},{"issue":"6","key":"987_CR130","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3390\/jcm9061641","volume":"9","author":"E Shim","year":"2020","unstructured":"Shim E, Mizumoto K, Choi W, Chowell G (2020) Estimating the risk of COVID-19 death during the course of the outbreak in Korea, February\u2013May 2020. J Clin Med 9(6):1641","journal-title":"J Clin Med"},{"key":"987_CR131","doi-asserted-by":"publisher","DOI":"10.23866\/BRNRev:2015-M0010","author":"O Sibila","year":"2015","unstructured":"Sibila O, Suarez-Cuartin G, Rodrigo-Troyano A, Anzueto A (2015) Corticosteroids and pneumonia in COPD: a dual effect? Barcelona Respiratory Netw. https:\/\/doi.org\/10.23866\/BRNRev:2015-M0010","journal-title":"Barcelona Respiratory Netw"},{"issue":"1","key":"987_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-04574-1","volume":"9","author":"A Singanayagam","year":"2018","unstructured":"Singanayagam A et al (2018) Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations. Nat Commun 9(1):1\u20136","journal-title":"Nat Commun"},{"issue":"11","key":"987_CR133","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S2213-2600(20)30447-1","volume":"8","author":"D Singh","year":"2020","unstructured":"Singh D, Halpin DM (2020) Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying? Lancet Respir Med 8(11):1065\u20131066","journal-title":"Lancet Respir Med"},{"issue":"5","key":"987_CR134","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.dsx.2020.06.054","volume":"14","author":"AK Singh","year":"2020","unstructured":"Singh AK, Majumdar S, Singh R, Misra A (2020) Role of corticosteroid in the management of COVID-19: a systemic review and a Clinician\u2019s perspective. Diabetes Metab Syndr Clin Res Rev 14(5):971\u2013978","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"6","key":"987_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.596","volume":"8","author":"C So","year":"2020","unstructured":"So C, Ro S, Murakami M, Imai R, Jinta T (2020) High-dose, short-term corticosteroids for ARDS caused by COVID-19: a case series. Respirol Case Rep 8(6):e00596","journal-title":"Respirol Case Rep"},{"issue":"6","key":"987_CR136","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00296-020-04584-7","volume":"40","author":"J Song","year":"2020","unstructured":"Song J, Kang S, Choi SW, Seo KW, Lee S, So MW, Lim DH (2020) Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs. Rheumatol Int 40(6):991\u2013995","journal-title":"Rheumatol Int"},{"issue":"13","key":"987_CR137","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2020.17023","volume":"324","author":"JA Sterne","year":"2020","unstructured":"Sterne JA et al (2020) Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 324(13):1330\u20131341","journal-title":"JAMA"},{"issue":"01","key":"987_CR138","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4236\/pp.2021.121002","volume":"12","author":"M Tagliati","year":"2021","unstructured":"Tagliati M et al (2021) Ciclesonide use in COVID-19: not all steroids are the same. Pharmacol Pharm 12(01):10","journal-title":"Pharmacol Pharm"},{"issue":"10239","key":"987_CR139","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/S0140-6736(20)30749-2","volume":"395","author":"C Tang","year":"2020","unstructured":"Tang C, Wang Y, Lv H, Guan Z, Gu J (2020) Caution against corticosteroid-based COVID-19 treatment. Lancet 395(10239):1759\u20131760","journal-title":"Lancet"},{"issue":"1","key":"987_CR140","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/15412555.2020.1712688","volume":"17","author":"NC Tangirala","year":"2020","unstructured":"Tangirala NC, O\u2019Conor R, Wolf MS, Wisnivesky JP, Federman AD (2020) Validity of the medication adherence rating scale for adherence to inhaled corticosteroids among older adults with asthma or chronic obstructive pulmonary disease. COPD J Chron Obstruct Pulmon Dis 17(1):74\u201380","journal-title":"COPD J Chron Obstruct Pulmon Dis"},{"issue":"12","key":"987_CR141","doi-asserted-by":"publisher","DOI":"10.2196\/23830","volume":"9","author":"J Terada-Hirashima","year":"2020","unstructured":"Terada-Hirashima J et al (2020) Efficacy and safety of inhaled ciclesonide in treating patients with asymptomatic or mild COVID-19 in the RACCO trial: protocol for a multicenter, open-label, randomized controlled trial. JMIR Res Protoc 9(12):e23830","journal-title":"JMIR Res Protoc"},{"issue":"3","key":"987_CR142","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/bjophthalmol-2020-316586","volume":"105","author":"ZX Thng","year":"2021","unstructured":"Thng ZX et al (2021) COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs. Br J Ophthalmol 105(3):306\u2013310","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"987_CR143","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/MPG.0000000000002729","volume":"70","author":"D Turner","year":"2020","unstructured":"Turner D et al (2020) Corona virus disease 2019 and paediatric inflammatory bowel diseases: global experience and provisional guidance (March 2020) from the paediatric IBD Porto group of European Society of paediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr 70(6):727","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"15","key":"987_CR144","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1001\/archinte.163.15.1801","volume":"163","author":"PD van der Linden","year":"2003","unstructured":"van der Linden PD, Sturkenboom MC, Herings RM, Leufkens HM, Rowlands S, Stricker BH (2003) Increased risk of Achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med 163(15):1801\u20131807","journal-title":"Arch Intern Med"},{"key":"987_CR145","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fmed.2020.00170","volume":"7","author":"N Veronese","year":"2020","unstructured":"Veronese N et al (2020) Use of corticosteroids in coronavirus disease 2019 pneumonia: a systematic review of the literature. Front Med 7:170","journal-title":"Front Med"},{"issue":"4","key":"987_CR146","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000111","volume":"2","author":"J Villar","year":"2020","unstructured":"Villar J, Confalonieri M, Pastores SM, Meduri GU (2020) Rationale for prolonged corticosteroid treatment in the acute respiratory distress syndrome caused by coronavirus disease 2019. Crit Care Explor 2(4):e0111","journal-title":"Crit Care Explor"},{"issue":"Suppl 2","key":"987_CR147","doi-asserted-by":"publisher","first-page":"275","DOI":"10.31138\/mjr.31.3.275","volume":"31","author":"P Vounotrypidis","year":"2020","unstructured":"Vounotrypidis P (2020) COVID-19: an archetype innate immunity reaction and modes of treatment. Mediterr J Rheumatol 31(Suppl 2):275","journal-title":"Mediterr J Rheumatol"},{"issue":"2","key":"987_CR148","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/CCM.0b013e3182a2727d","volume":"42","author":"CH Wang","year":"2014","unstructured":"Wang CH et al (2014) Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure. Crit Care Med 42(2):313\u2013321","journal-title":"Crit Care Med"},{"issue":"31","key":"987_CR149","doi-asserted-by":"publisher","first-page":"e21597","DOI":"10.1097\/MD.0000000000021597","volume":"99","author":"K Wang","year":"2020","unstructured":"Wang K, Tan F, Zhou R, Liu D, Ni Z, Liu J, Luo F (2020a) Therapeutic response to corticosteroids in a critically ill patient with COVID-19: a case report. Medicine 99(31):e21597","journal-title":"Medicine"},{"issue":"1","key":"987_CR150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"Y Wang","year":"2020","unstructured":"Wang Y et al (2020b) A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia. Signal Transduct Target Ther 5(1):1\u20133","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"987_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10787-010-0056-2","volume":"19","author":"MW Whitehouse","year":"2011","unstructured":"Whitehouse MW (2011) Anti-inflammatory glucocorticoid drugs: reflections after 60 years. Inflammopharmacology 19(1):1\u20139","journal-title":"Inflammopharmacology"},{"issue":"6","key":"987_CR152","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4187\/respcare.06314","volume":"63","author":"DM Williams","year":"2018","unstructured":"Williams DM (2018) Clinical pharmacology of corticosteroids. Respir Care 63(6):655\u2013670","journal-title":"Respir Care"},{"issue":"9","key":"987_CR153","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/0885066617711386","volume":"34","author":"P Wohlfarth","year":"2019","unstructured":"Wohlfarth P, Agis H, Gualdoni GA, Weber J, Staudinger T, Schellongowski P, Robak O (2019) Interleukin 1 receptor antagonist anakinra, intravenous immunoglobulin, and corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis. J Intensive Care Med 34(9):723\u2013731","journal-title":"J Intensive Care Med"},{"issue":"2","key":"987_CR154","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ygeno.2020.12.041","volume":"113","author":"HS Wong","year":"2021","unstructured":"Wong HS, Guo CL, Lin GH, Lee KY, Okada Y, Chang WC (2021) Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy. Genomics 113(2):564\u2013575","journal-title":"Genomics"},{"issue":"12","key":"987_CR155","doi-asserted-by":"publisher","first-page":"e4230","DOI":"10.1210\/clinem\/dgaa627","volume":"105","author":"J Wu","year":"2020","unstructured":"Wu J et al (2020) Systemic corticosteroids and mortality in severe and critical COVID-19 patients in Wuhan. China J Clin Endocrinol Metab 105(12):e4230\u2013e4239","journal-title":"China J Clin Endocrinol Metab"},{"issue":"3","key":"987_CR156","first-page":"179","volume":"43","author":"JZ Xiao","year":"2004","unstructured":"Xiao JZ et al (2004) Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy. Zhonghua Nei Ke Za Zhi 43(3):179\u2013182","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"987_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198089","volume":"290","author":"Y Yamasaki","year":"2020","unstructured":"Yamasaki Y (2020) The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide. Virus Res 290:198089","journal-title":"Virus Res"},{"issue":"10","key":"987_CR158","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1007\/s12630-020-01700-w","volume":"67","author":"SS Yang","year":"2020","unstructured":"Yang SS, Lipes J (2020) Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series. Can J Anaesth 67(10):1462\u20131464","journal-title":"Can J Anaesth"},{"issue":"9","key":"987_CR159","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.cmi.2020.06.020","volume":"26","author":"JW Yang","year":"2020","unstructured":"Yang JW, Yang L, Luo RG, Xu JF (2020a) Corticosteroid administration for viral pneumonia: COVID-19 and beyond. Clin Microbiol Infect 26(9):1171\u20131177","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"987_CR160","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.jinf.2020.03.062","volume":"81","author":"Z Yang","year":"2020","unstructured":"Yang Z, Liu J, Zhou Y, Zhao X, Zhao Q, Liu J (2020b) The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect 81(1):e13\u2013e20","journal-title":"J Infect"},{"issue":"27","key":"987_CR161","doi-asserted-by":"publisher","first-page":"E756","DOI":"10.1503\/cmaj.200645","volume":"192","author":"Z Ye","year":"2020","unstructured":"Ye Z et al (2020) Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis. CMAJ 192(27):E756\u2013E767","journal-title":"CMAJ"},{"issue":"8","key":"987_CR162","first-page":"1411","volume":"49","author":"M Yousefifard","year":"2020","unstructured":"Yousefifard M et al (2020) Corticosteroids on the management of coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis. Iran J Public Health 49(8):1411","journal-title":"Iran J Public Health"},{"issue":"9","key":"987_CR163","doi-asserted-by":"publisher","first-page":"416","DOI":"10.5694\/mja2.50577","volume":"212","author":"L Zha","year":"2020","unstructured":"Zha L et al (2020) Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19). Med J Aust 212(9):416\u2013420","journal-title":"Med J Aust"},{"issue":"6","key":"987_CR164","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.eururo.2020.03.030","volume":"77","author":"H Zhang","year":"2020","unstructured":"Zhang H et al (2020) Identification of kidney transplant recipients with coronavirus disease 2019. Eur Urol 77(6):742\u2013747","journal-title":"Eur Urol"},{"issue":"1","key":"987_CR165","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246030","volume":"16","author":"XB Zhang","year":"2021","unstructured":"Zhang XB et al (2021) Risk factors for mortality of coronavirus disease-2019 (COVID-19) patients in two centers of Hubei province, China: a retrospective analysis. PLoS ONE 16(1):e0246030","journal-title":"PLoS ONE"},{"key":"987_CR166","doi-asserted-by":"publisher","unstructured":"Zhou ZG et al (2020) Short-term moderate-dose corticosteroid plus immunoglobulin effectively reverses COVID-19 patients who have failed low-dose therapy. https:\/\/doi.org\/10.21203\/rs.3.rs-34078\/v1","DOI":"10.21203\/rs.3.rs-34078\/v1"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-00987-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-00987-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-00987-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T15:02:47Z","timestamp":1700578967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-00987-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":166,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-00987-z","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"assertion":[{"value":"13 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}